Antimicrobial resistance (AMR), a pressing and substantial global health threat, is in the spotlight this September 2024 when the UN hosts a second high-level meeting on the issue. With millions of lives at risk and decades of medical progress threatened, urgent action is required to address this global challenge. Our recent comment published in Lancet Microbe1Ā identifies five major blind spots in the current approach to tackling AMR, and this blog aims to highlight these blind spots and the 5 āIās as the way forward.
First blind spot: Overemphasis on high-income nations: While AMR is a global problem, most research and policy efforts are focused on high-income countries. Yet, low- and middle-income countries (LMICs) face the most significant challenges, with higher rates of infectious diseases and widespread antibiotic misuse. AMR strategies found to be effective in high-income settings may not be appropriate for LMICs due to differences in resources, infrastructure, and sociocultural factors.
The way forward – Invest: Increased investment in LMICs, focusing on improving water, sanitation, and hygiene (WASH), expanding vaccines, and creating solutions that fit local needs.
Second blind spot: Neglecting primary care providers: Most AMR efforts focus on hospitals, but over 85% of antibiotics are used in communities. These are often prescribed by private doctors, pharmacists, and informal practitioners. In many rural and underserved areas of LMICs, these providers are the first point of contact for healthcare.
The way forward – Involve: Extending antibiotic stewardship programs to include primary care and community-based providers is crucial in reducing unnecessary antibiotic prescriptions and dispensing.
Third blind spot: Antibiotic overuse in livestock and agriculture: A significant but often ignored cause of AMR is the use of antibiotics in livestock and agriculture, where usage far exceeds that in humans. This is especially true in LMICs, where regulations are poorly regulated, and antibiotics are commonly used to promote animal growth.
The way forward – Intervene: Strengthening collaboration between the health and agriculture sectors is essential, and more robust policies to reduce the use of antibiotics in animals are required.
Fourth blind spot: Lack of accessible diagnostics: Antibiotics are often prescribed in many settings without a clear diagnosis because access to affordable diagnostic tools is limited. Reliance on empirical treatment, particularly in LMICs, significantly drives antibiotic misuse. Rapid point-of-care tests can help reduce unnecessary antibiotic prescriptions by providing quick and accurate diagnoses.
The way forward – Innovate: Increased investment is needed to develop low-cost, robust diagnostic tools that work well in resource-limited areas.
Fifth blind spot: Overlooked informal sector: In many LMICs, informal healthcare providers (IPs), who often have little to no medical training, are key sources of antibiotics. These providers are valued and trusted by their communities
and offer accessibility and affordability services, but they have been reported to contribute to antibiotic overuse.
The way forward – Integrate: To effectively address AMR, IPs must be included in antibiotic stewardship efforts through training, regulation, and pragmatic strategies suitable for local settings.
To make progress in the fight against AMR, we stress the importance of recognizing and addressing these five blind spots. We must shift our focus to LMICs, primary care providers, and informal healthcare sectors. In addition, we need to reduce antibiotic use in livestock and invest in affordable diagnostic tools. By tackling these challenges, we can create a more robust and effective global strategy to fight AMR.
Dr. Poshan Thapa is a Postdoctoral Fellow at the School of Population and Global Health at McGill University, Canada. He holds a PhD in Public Health from the University of New South Wales, Australia, and a Master in Public Health degree from Manipal University, India. Dr. Thapa’s work focuses on tuberculosis care, informal and community-based healthcare providers, primary care, and private-sector engagement in health systems. His research on antibiotic use centers on the informal sector, particularly the practices of informal healthcare providers in low- and middle-income countries.
India Health Fund is registered as Confluence for Health Action and Transformation Foundation (CHATF), a Section 8
charitable company incorporated in India, supported by the Tata Trusts.